CAS 116289-53-3

Fórmula: C25H19N3O2S

InChI: InChI=1S/C25H19N3O2S/c29-23(17-6-2-1-3-7-17)18-8-4-10-20(14-18)27-24(30)21-11-13-28-22(21)16-31-25(28)19-9-5-12-26-15-19/h1-15,25H,16H2,(H,27,30)/t25-/m1/s1

Chave InChI: PQQFNXGONTVQLM-RUZDIDTESA-N

SMILES: C1C2=C(C=CN2[C@H](S1)C3=CN=CC=C3)C(=O)NC4=CC=CC(=C4)C(=O)C5=CC=CC=C5

Tulopafant

CAS: 116289-53-3

Tulopafant

Fórmula: C₂₅H₁₉N₃O₂S

Pureza: ≥98%

Peso molecular: 425.5

Ref: 54-BUP21633

Tulopafant

CAS: 116289-53-3

Ref: IN-DA008YY6

Tulopafant

CAS: 116289-53-3

Tulopafant is a novel linker drug that has shown efficacy in treating ischemia/reperfusion injury. It acts by binding to and activating neutrophils, which are important for the body's immune response to infection. Tulopafant promotes the release of reactive oxygen species from neutrophils, and it also neutralizes reactive nitrogen species. This drug has been shown to be effective in reducing ventricular fibrillation in vitro studies and may be useful as a treatment for myocardial infarcts.

Fórmula: C₂₅H₁₉N₃O₂S

Pureza: Min. 95%

Peso molecular: 425.5 g/mol

Ref: 3D-REA28953

Tulopafant

CAS: 116289-53-3

Tulopafant (RP 59227) is a potent platelet-activating factor (PAF) antagonist that increases capillary patency and prolongs allograft heart survival.

Fórmula: C₂₅H₁₉N₃O₂S

Pureza: 99.38%

Cor e Forma: Yellow Solid

Peso molecular: 425.5

Ref: TM-T17178